Kissei Pharmaceutical Reports No Shares Acquired in Latest Buyback Period

TOKYO, Aug 06 (Pulse News Wire) – Kissei Pharmaceutical CO.,LTD. (4547.T) reported that it did not acquire any shares during the latest buyback period ending July 31, 2026.

The company had previously announced plans to repurchase up to 1,489,000 ordinary shares, representing approximately 2.85% of outstanding shares excluding treasury stock, with a total acquisition value cap of ¥14.89 billion. The buyback was set to run from May 11, 2026, to December 31, 2026, through open market purchases on the Tokyo Stock Exchange and ToSTNeT-3.

As of July 31, 2026, the cumulative number of shares acquired remains at zero, with a total expenditure of ¥0. The board resolution approving the share repurchase was made at the May 11, 2026, board meeting.